CMS has suspended Gold Kidney of Florida from enrolling new members into one of its Medicare Advantage plans after state regulators found significant compliance and financial oversight failures.
On Sept. 12, the Florida Office of Insurance Regulation issued a consent order barring Phoenix-based Gold Kidney Health Plan from enrolling new members through Dec. 15, 2025, citing failures to obtain required executive approvals, delays in mandatory filings, missing financial documentation and wide gaps between projected and actual financial performance. The order allows Gold Kidney to resume enrollments effective Jan. 1, 2026, provided the company is back in good standing.
CMS followed with an intermediate sanction Sept. 29, halting enrollment in the Florida MA plan until regulators lift the order.
Gold Kidney has until Oct. 10 to submit a rebuttal and until Oct. 15 to request a hearing, though the suspension remains in effect during appeals.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.